4CPS-123 Role of docetaxel in combination with cisplatin and capecitabine in advanced gastric cancer

BACKGROUND: Advanced gastric cancer (AGC) does not have a chemotherapy regimen accepted as standard. Docetaxel has demonstrated benefits associated with cisplatin and 5-fluorouracil in a phase III trial but with modest results and high toxicity, and we need to know how it impacts on more fragile pat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Eur J Hosp Pharm
Glavni autori: Torròn, A Martinez, Alvarez-Manceñido, F, Garcia, I Zapico, Palomo, A Rodriguez, Calero, M Alaguero, Carmona-Bayonas, A, Medical, E Martínez de Castro, Azkarate, A, Mangas, M, Lozano-Blázquez, A
Format: Artigo
Jezik:Inglês
Izdano: BMJ Group 2018
Teme:
Section 4: Clinical pharmacy services
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535175/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.214
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items